Align Financial’s United Therapeutics UTHR Stock Holding History

Align Financial’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$542	Buy	+1	New	+$517	﹤0.01%	472

Other funds holding UTHR

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Align Financial's UTHR Position: Q3 2026 in Review

Align Financial opened a new position in United Therapeutics (UTHR) in Q3 2026: 1 share worth $542. The stake represents ﹤0.01% of the portfolio and ranks #472 among its holdings.

123 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Align Financial held 1 share of United Therapeutics worth $542 as of Q3 2026.
United Therapeutics was a new Align Financial position in Q3 2026.
United Therapeutics made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #472 holding.
123 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.